Melissa Biggs was driving her car when she was given a death sentence. A cardiopulmonary specialist was giving the actress, one of the beach beauties from the Baywatch television series, results from ...
MOLINE, Ill. — November is Alpha-1 Awareness Month, a time dedicated to increasing understanding of Alpha-1 Antitrypsin Deficiency, a rare genetic condition that can cause serious lung and liver ...
TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing expected by the end of the year Tessera to receive $150 ...
The big biotech, which has made genetic medicine a focus in recent years, is paying Tessera $150 million for rights to a ...
Korro Bio, Inc., a biopharmaceutical company focused on RNA editing therapies, announced that the European Medicines Agency (EMA) has granted orphan drug designation for its investigational drug ...
When you learn you have genetic chronic obstructive pulmonary disease (COPD), the first step is to educate yourself about your diagnosis. If you have genetic COPD, also called alpha-1, it means you ...
November is Alpha-1 Awareness Month, a genetic condition that can lead to serious lung and liver disease. Right now, there is no cure and it is often undiagnosed.
Korro Bio, Inc. announced that its investigational drug KRRO-110 has received orphan drug designation from the FDA for treating Alpha-1 Antitrypsin Deficiency (AATD). This designation highlights the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback